利用主动脉创伤基金会注册数据库开发并验证钝性胸主动脉损伤患者胸主动脉腔内修复术后院内死亡风险预测工具
基于主动脉创伤基金会(ATF)国际注册数据库,纳入2016年1月至2022年6月因钝性胸主动脉损伤(BTAI)接受胸主动脉腔内修复(TEVAR)的448例患者,构建术前模型与全模型预测院内全因死亡。ATF数据集中TEVAR后院内全因死亡率为8.5%;全模型区分度中等偏上(AUC 0.84,95%CI 0.74-0.91),但校准图显示两模型倾向低估风险。
要点
- ATF注册库中因BTAI行TEVAR的患者院内全因死亡率为8.5%。
- 全模型(含术前与术后变量)预测表现最佳,AUC 0.84(95%CI 0.74-0.91)。
- 两模型校准图均倾向低估风险,主要见于中等风险病例。
核心结论
- 本研究开发并验证了一个纳入若干术前和术后变量的当代风险预测模型,对早期死亡有较强预测能力。
- 该模型可合理预测院内全因死亡,有助于医生进行风险分层并向患者及其照护者提供信息,但须考虑其固有局限性,仅应视为可能补充临床判断和共享决策的辅助工具。
研究设计与样本
- 基于主动脉创伤基金会(ATF)数据库,识别2016年1月至2022年6月注册的因BTAI接受TEVAR的所有患者,排除接受药物治疗或开放修复者。
- 主要结局为二分类院内全因死亡;构建术前模型(仅纳入TEVAR前变量或意向性治疗)和全模型(亦纳入TEVAR后变量或符合方案)。
- ATF注册库截至2022年6月共944例,其中448例接受TEVAR并纳入研究人群;按3:1随机抽样分为推导队列(336例;75.0%)和验证队列(112例;25.0%)。
- 中位年龄38岁,男性350例(78%);最终分析纳入38个变量,其中17个纳入术前模型、9个纳入全模型、12个因方差极低或与其他变量强相关而被排除。
主要发现
- ATF数据集中因BTAI行TEVAR与8.5%的院内全因死亡相关。
- ATF数据集两模型的校准图均倾向低估风险,主要见于中等风险病例。
- 所有模型区分能力为中等;表现最佳者为ATF数据集的全模型,受试者工作特征曲线下面积(AUC)为0.84(95%CI 0.74-0.91),密度图亦支持。
临床怎么用
- 作者认为该模型可合理预测院内全因死亡,从而协助医生进行风险分层并向患者及其照护者提供信息,但仅应视为可能补充临床判断和共享决策的辅助工具。
局限性
- 两模型校准图显示倾向低估风险,主要见于中等风险病例。
- 所有模型区分能力仅为中等。
- 作者指出须考虑模型的固有局限性,仅应将其视为辅助工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of our present effort was to use an international blunt thoracic aortic injury (BTAI) registry to create a prediction model identifying important preoperative and intraoperative factors associated with postoperative mortality, and to develop and validate a simple risk prediction tool that could assist with patient selection and risk stratification in this patient population. METHODS: For the purpose of the present study, all patients undergoing thoracic endovascular aortic repair (TEVAR) for BTAI and registered in the Aortic Trauma Foundation (ATF) database from January 2016 as of June 2022 were identified. Patients undergoing medical management or open repair were excluded. The primary outcome was binary in-hospital all-cause mortality. Two predictive models were generated: a preoperative model (i.e. only including variables before TEVAR or intention-to-treat) and a full model (i.e. also including variables after TEVAR or per-protocol). RESULTS: Out of a total of 944 cases included in the ATF registry until June 2022, 448 underwent TEVAR and were included in the study population. TEVAR for BTAI was associated with an 8.5% in-hospital all-cause mortality in the ATF dataset. These study subjects were subsequently divided using 3:1 random sampling in a derivation cohort (336; 75.0%) and a validation cohort (112; 25.0%). The median age was 38 years, and the majority of patients were male (350; 78%). A total of 38 variables were included in the final analysis. Of these, 17 variables were considered in the preoperative model, 9 variables were integrated in the full model, and 12 variables were excluded owing to either extremely low variance or strong correlation with other variables. The calibration graphs showed how both models from the ATF dataset tended to underestimate risk, mainly in intermediate-risk cases. The discriminative capacity was moderate in all models; the best performing model was the full model from the ATF dataset, as evident from both the Receiver Operating Characteristic curve (Area Under the Curve 0.84; 95% CI 0.74-0.91) and from the density graph. CONCLUSIONS: In this study, we developed and validated a contemporary risk prediction model, which incorporates several preoperative and postoperative variables and is strongly predictive of early mortality. While this model can reasonably predict in-hospital all-cause mortality, thereby assisting physicians with risk-stratification as well as inform patients and their caregivers, its intrinsic limitations must be taken into account and it should only be considered an adjunctive tool that may complement clinical judgment and shared decision-making.
引用
- D'Oria M, Pipitone MD, DuBose J, et al. Development and Validation of a Risk Prediction Tool for In-hospital Mortality After Thoracic Endovascular Repair in Patients with Blunt Thoracic Aortic Injury Using the Aortic Trauma Foundation Registry. Ann Vasc Surg. 2023. PMID: 37922958. doi:10.1016/j.avsg.2023.09.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。